Imatib Mesylate Medicine

Imatib Mesylate Medicine Exporter, Distributor, Supplier, Trading Company, Delhi, India

Imatib Mesylate Medicine Exporter, Distributor, Supplier, Trading Company, Delhi, India

Imatib Mesylate Medicine Exporter, Distributor, Supplier, Trading Company, Delhi, India

Imatib Mesylate Medicine Exporter, Distributor, Supplier, Trading Company, Delhi, India.Backed by qualified administrative personnel, we have been passionately engaged in offering Cipla Imatinib Mesylate 400 mg. The provided medicine is widely used to treat myeloid leukemia and gastrointestinal stromal tumors. This medicine is formulated by utilizing the finest quality chemicals compounds with the aid of pioneering methodology in tune with international medical norms. To meet the specific demands of our clients, we are offering this Cipla Imatinib Mesylate 400 mg in various packaging options at pocket friendly prices.

Imatinib Mesylate Medicine

Veenat contains Imatinib Mesylate. Veenat is manufactured by Natco Pharma Ltd. Veenat is available in 100 Mg Capsules and 400 Mg Tablets. Veenat comes in pack of 30 tablets and 120 capsules.

Specifications

 

  • Content: Imatinib
  • Form: Tablets & Capsules
  • Strength: 100mg & 400mg
  • Packing: Pack of 30 and 120  Tablets
  • Manufacturer: Natco Pharma Limited.
  • QQ: 1485238373

 

This product is priced at 25% of the cost of its generic drug.

Note: Veenat is a prescription Drug and should be used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

Features:

  • Highly effective
  • Ensures stability
  • Prolonged shelf life
  • Safe and effective

Imatib Mesylate Medicine Exporter, Distributor, Supplier, Trading Company, Delhi, India

Send your enquiry to find the

Cost of Imatib Mesylate Medicine in Australia, Brazil, China, Canada, Eqypt, Europe, France, Germany, Hongkong, India, Iran, Italy, Mexico, Pakistan, Poland, Spain, Singapore, Thailand, Russia, Romania, UK, Middle East, UAE, Ukraine.